Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3711852019 | Selegiline-containing product in transdermal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3711853012 | Product containing selegiline in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4625461000052114 | läkemedel som innehåller selegilin, transdermal läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Selegiline-containing product in transdermal dose form | Is a | Product manufactured as transdermal dose form (product) | true | Inferred relationship | Some | ||
| Selegiline-containing product in transdermal dose form | Has active ingredient | Selegiline (substance) | true | Inferred relationship | Some | 1 | |
| Selegiline-containing product in transdermal dose form | Has manufactured dose form | Transdermal dose form (dose form) | true | Inferred relationship | Some | ||
| Selegiline-containing product in transdermal dose form | Is a | Product containing selegiline (medicinal product) | true | Inferred relationship | Some | ||
| Selegiline-containing product in transdermal dose form | Plays role | Antidepressant therapeutic role | true | Inferred relationship | Some | ||
| Selegiline-containing product in transdermal dose form | Is a | Medicinal product acting as antidepressant agent (product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| selegilin 9 mg/24 timmar, depåplåster | Is a | False | Selegiline-containing product in transdermal dose form | Inferred relationship | Some | |
| selegilin 12 mg/24 timmar, depåplåster | Is a | False | Selegiline-containing product in transdermal dose form | Inferred relationship | Some | |
| selegilin 6 mg/24 timmar, depåplåster | Is a | False | Selegiline-containing product in transdermal dose form | Inferred relationship | Some | |
| Selegiline only product in transdermal dose form | Is a | True | Selegiline-containing product in transdermal dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR